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Review Article
Does Hypertension Develop After Reflux Nephropathy in
Childhood? A Critical Review of the Recent English Literature
Sik-Nin Wong
Urinary tract infection in children is important, not only because of the acute infectious episode, but also
because of underlying urologic abnormalities and consequential renal scarring which, in turn, is believed to
cause long-term sequelae such as hypertension, renal insufficiency, and complications in pregnancy. It is
reasonable to anticipate the development of hypertension after renal scarring, as the renin-angiotensin-aldosterone
system is activated; however, evidence for this widely held concept is scanty. In a survey of the English literature
from 1989–2003, nine articles reporting the prevalence of hypertension in reflux nephropathy were identified
and are described in this review. From six cohort studies that followed patients for 15–29 years to adulthood,
the reported risk of hypertension ranged from 5.6–27.9%; however, only one study reported a significantly
greater risk in patients with renal scarring compared to a non-scarred control group. In four other studies that
also included non-scarred, comparator groups, the risks were similar in patients and controls. There was a
trend towards increasing blood pressure with more severe scarring. The observed variation in results was likely
due to different methodologic limitations, such as referral bias, a significant percentage of defaulters, failure to
correct for confounding factors, and different methods of measuring blood pressure and defining hypertension.
These and related issues are critically reviewed here. [Hong Kong J Nephrol 2005;7(1):3–8]
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INTRODUCTION
Urinary tract infection (UTI) is common in childhood,
affecting about 5% of febrile children under 5 years
of age [1]. Vesicoureteric reflux (VUR) is frequently
associated with febrile UTI and, in previous reports,
was present in 12–50% of cases. Renal scarring was a
common finding in children with UTI, and its
prevalence increased with age, being 10% in preterm
infants with VUR, 26% in children up to 8 years old,
47% in children over 8 years old, and 94% in adults
[2]. The severity of renal scarring was related to the
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number of pyelonephritic episodes [3], the grades of
VUR [4], and the delay in diagnosis and treatment
[5,6]. Although it is now recognized that renal
parenchymal damage may result from congenital
dysplasia or pyelonephritic damage, it is clinically
difficult to differentiate between these two causes, and
previous studies have included them together. Current
dogma is that renal scarring in early life will lead to
later complications such as chronic renal insufficiency,
hypertension, and complications during pregnancy [1].
It is logical to expect the development of hyper-
tension secondary to reflux nephropathy because pa-
tients with such nephropathy are reported to have high
plasma renin activity (PRA) [7], which would lead to
increased secretion of angiotensin II and aldosterone,
with subsequent sodium and fluid retention. There is
also increasing evidence of local modulation of the
renin-angiotensin-aldosterone system, thus causing
intraglomerular hypertension, secondary glomeru-
losclerosis, and renal insufficiency [2].
However, despite the theoretical plausibility, the
reported incidence of hypertension in patients with
reflux nephropathy has been variable. A review by the
American Academy of Pediatrics in 1999 mentioned
that the rate of hypertension in studies of reflux ne-
phropathy varied from 0–50%. The rate is apparently
lowest in patients with low-grade VUR and those with
the least renal scarring. However, the quality of the
studies relating reflux nephropathy to renal failure and
hypertension has been poor [1].
EVIDENCE FROM THE LITERATURE
Does reflux nephropathy in children lead to hyper-
tension in later life and, if so, what is the risk? We
performed a literature search using the medical sub-
ject headings or key words: “urinary tract infection” or
“pyelonephritis”; “vesicoureteral reflux” or “renal
scarring” or “reflux nephropathy”; and “hypertension”
or “blood pressure”. The search strategy was applied
to MEDLINE and EMBASE from January 1989 to
November 2003. The title and abstracts of the 144 ar-
ticles retrieved were studied, and nine relevant articles
were identified. The reference lists from retrieved
articles were also reviewed to include any missing
references and references in non-indexed journals. For
this review, we defined “reflux nephropathy” as renal
parenchymal damage associated with primary VUR;
hence, we excluded articles reporting cases with known
congenital or obstructive renal malformations. The nine
articles are briefly described below and are summarized
in Table 1.
Jacobson et al from Stockholm, Sweden, identified
53 patients with UTI and renal scarring on intravenous
pyelogram (IVP) between 1951 and 1967 [8,9]. How-
ever, only 30 patients were evaluable for the study
outcome. In this retrospective cohort study, the mean
age of patients at diagnosis was 2.8 years (range,
0.7–13 years), and mean age was 33 years (range, 22–
41 years) at the time of study. Hence, the follow-up
duration was 27 ( 6 years (mean ( standard deviation
[SD]). Blood pressure (BP) was measured with mer-
cury sphygmomanometry. Overall, seven patients had
hypertension (BP > 140/90 mmHg), including three
patients with bilateral scarring and end-stage renal
failure, and four with unilateral scars. Diastolic and/or
mean BP values for patients were higher than those
for controls. However, there was no difference in BP
between patients with severe versus mild scarring
(Grade A/B vs C/D).
Bailey et al reported outcomes for 31 infants with
gross VUR corrected by ureteric-reimplantation surgery
from 1952–1970 [10]. Five infants had died before 1
year of age. Four patients were lost to follow-up, and
one died as the result of a traffic accident at age 11
years. The remaining 21 patients were assessed in 1990,
after a follow-up period of 16–37 years. Four patients
had normal kidneys and normal renal function; one of
them had hypertension. Seventeen patients had reflux
nephropathy detected before the age of 3 years. Among
these 17 patients, four had bilateral renal scarring, of
which two had chronic renal insufficiency, with hyper-
tension in one. The other 13 patients had unilateral re-
nal scarring, of which one had a single kidney, end-
stage renal failure and hypertension, and another two
had diastolic hypertension. Thus, the overall incidence
of hypertension was 23.8% (5 of 21 patients).
Wolfish et al from Canada reviewed the cases of
146 children with UTI and primary VUR: 128 patients
had an IVP result available, and 45 had renal scarring
[11]. The mean age at diagnosis was 5 years, and that
at the time of study was 14.4 years, thus giving a mean
follow-up duration of 9.6 ( 3.2 years. BP was measured
by a Dinamap® 8100 device (GE Healthcare, Chalfont
St. Giles, UK). The researchers found that no patients
had hypertension, although BP percentiles were pro-
gressively higher from the non-scarring to the focal-
scarring and diffuse-scarring groups.
In 1996, Martinell et al from Sweden reported
outcomes for 111 women with recurrent UTI: 54
women had renal scarring and 69 had VUR [12]. The
outcomes were compared with data for a control group
of 48 patients without UTI. Patients were diagnosed
(from 1956 to 1968) at a mean age of 5 years, and were
studied at age 15–33 years, thus giving a mean follow-
up duration of 14.8 years. Spot BP was measured us-
ing a mercury sphygmomanometer. The incidence of
hypertension was 5.6% (3/54 patients) in the renal-
scarring group, 3.5% (2/57) in the non-scarring group,
and 2.1% (1/48) in the control group.
In the same year, Goonasekera et al reported 15-
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year follow-up data for a prospectively studied cohort
of 100 children from London, England, who had UTI
and VUR [7]. These children were diagnosed between
1960 and 1978 when aged 2–15 years. Their BP
(measured by Dinamap® device), PRA and glomerular
filtration rates (GFR) were measured every 5 years.
Patients with hypertension were excluded from further
assessments, as were five patients who had undergone
nephrectomy. At the 15-year assessment (follow-up
duration, 20–31 years), 55 patients were assessed.
Overall, 18 of the 100 patients had hypertension, in-
cluding one boy who died from hypertensive enceph-
alopathy. Most of the hypertensive patients (83.3%;
15/18) developed the condition at age 15–30 years.
PRA increased progressively from baseline to the 10-
year assessment, with no further increase at the 15-
year assessment. The investigators estimated that the
probability of remaining free of hypertension after 5,
10, and 15 years was 95%, 84%, and 79%, respectively.
Smellie et al also prospectively followed 226 chil-
dren with UTI and VUR managed at a London clinic
[13]. The patients were diagnosed between 1955 and
1980. Renal scarring (detected by IVP) was present in
85 patients (38%) and absent in 141 (62%). All patients
were assessed in 1988 (after 10–35 years’ follow-up)
by measuring GFR, and BP using a mercury sphyg-
momanometer, and by performing 99mTc-dimercapto-
succinic acid (DMSA) scintigraphy. In 1995, a further
postal survey was conducted in these patients, and 161
(71%) responded, thus extending the follow-up period
to 18–44 years (mean, 28.8 years). Among findings at
the last follow-up visit, 21 of 85 patients (24.7%) with
renal scarring, and 3 of 141 non-scarred patients
(2.1%), had sustained hypertension. Of particular note,
one girl with renal scarring died from intracranial
bleeding due to malignant hypertension.
Three recent studies used ambulatory BP-
monitoring (ABPM) in children with reflux nephro-
pathy. Wennerstrom et al reported a population-based,
prospective-cohort study in Sweden [14,15]. They fol-
lowed 1,221 children with UTI, and studied 53 of 74
patients in this cohort who had renal scarring. From
the patients without renal scarring, 47 matched controls
were selected. Patient ages at assessment were 16–26
years, giving a median follow-up period of 22 years.
BP was measured by ABPM (SpaceLabs 90207;
Spacelabs Medical Inc, Issaquah, WA, USA). Patients
also had their GFR, PRA, and atrial natriuretic pep-
tide (ANP) level measured. Hypertension, which was
defined as mean systolic or diastolic BP above the 95th
percentiles for adult norms, was present in 9.4% (5/53)
of patients with renal scarring and in 6.4% (3/47) of
non-scarred patients. The researchers also found that,
while PRA was similar in the two groups, ANP was
significantly greater in patients with rather than those
without renal scarring. The investigators suggested that
ANP may have a protective effect against hypertension
in such patients.
The second study using ABPM in patients with
reflux nephropathy was reported by Patzer et al from
Heidelberg, Germany, in 2003 [16]. Among 84 chil-
dren with UTI, 61 were available for assessment using
ABPM (SpaceLabs 90207) at age 5.9–18 years. All
patients were followed up for a minimum of 5 years.
Overall, 27.9% (17/61) of patients had hypertension,
with mean BP above the 95th percentiles for age and
sex. When compared with normal children, the patients
had a greater elevation of mean 24-hour systolic and
mean BP values, with fewer nocturnal dips than in
controls. SD scores for BP correlated positively with
the grade of renal scarring found on DMSA scans.
The third ABPM study was conducted by Lama et
al in 2003 [17]. The authors described a retrospective
case series of 100 children with primary VUR and renal
scarring who had been followed up for at least 5 years
at a center in Naples, Italy. The mean age at diagnosis
was 3.8 years, whereas that at the time of study was
13.5 years. Hypertension was assessed by ABPM us-
ing a SpaceLabs 90207 device. No patients had hyper-
tension, as defined by 24-hour mean BP values above
the 95th percentiles for age and sex. However, patients
with severe rather than mild scarring on DMSA had
a significantly lower creatinine clearance, and signi-
ficantly greater albuminuria, PRA, 24-hour/daytime/
night-time systolic BP/diastolic BP/mean BP. The
proportion of patients with a BP load of > 30% was
42% (21/50) in patients with severe renal scarring, and
16% (8/50) in those with mild scarring.
DISCUSSION
The designs and main findings of the nine retrieved
study articles are summarized in Table 1. The reported
prevalence of hypertension in patients with renal
scarring ranged from 5.6–27.9%. The data in Table 1
suggest that the prevalence of hypertension increased
with the duration of follow-up and patient age at as-
sessment. Of three studies in which patients were aged
less than 20 years and had been followed up for less
than 10 years, two reported that no patients had hyper-
tension [11,17] and one reported a prevalence of hy-
pertension of 27.9% by ABPM [16]. Of six studies
in which patients were over 20 years old and had been
followed up for 15–29 years, the reported prevalence
of hypertension was 5.6–24.7% [7,8,12,13,15]. Overall,
the highest rates of hypertension were noted in the
studies by Smellie et al [13] and Bailey et al [10], both
of which had long durations of follow-up.
Only five studies included a comparator group of
patients without renal scarring [10–13,15]. Although
no formal statistical analysis was reported, the risk of
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hypertension was greater in scarred than non-scarred
patients (24.7% vs 2.1%) in the study by Smellie et al
[13], whereas in three other studies, no difference
between scarred and non-scarred patients was found
[10,12,15]; however, patient numbers were small. In
the fifth study, no hypertension was detected in either
the patient or control group [11].
It remains controversial as to whether hyperten-
sion is worse in patients with severe scarring com-
pared to patients with mild scarring or normal kidneys.
Jacobson et al reported no difference in BP between
patients with severe versus mild scarring [8]. However,
studies reported more recently, and which used ABPM,
showed that ambulatory BP parameters were greater in
groups with severe rather than mild scarring, although
no patients in these studies had hypertension [11,17].
Does currently available evidence support the con-
cept that reflux nephropathy leads to hypertension?
For studies to recognize reflux nephropathy as a speci-
fic causal factor of hypertension, a genuine association
between the two conditions must be demonstrated, as
must true causation, as summarized in Table 2 [18].
Clearly, the retrieved studies in this review had several
limitations.
Firstly, most were retrospective studies, and only
three had prospectively followed cohorts [7,13,15].
Only five studies included a comparator group of pa-
tients without renal scarring [10–13,15]. All studies
recruited patients in follow-up clinics and were
therefore subject to referral bias, except for one
population-based study in unselected patients from
the general population [15].
Secondly, there was a high dropout rate in some
studies. For instance, one trial identified 53 patients
but studied only 30 [8]. Seven patients were found to
be hypertensive and 23 had dropped out. The prevalence
of hypertension could have varied from 13.2% (7/53)
to 56.6% ([7+23]/53).
Thirdly, other confounding variables were generally
not mentioned in the studies retrieved. Hypertension is
a multifactorial condition that may be influenced by
gender, body mass index and the presence or absence
of a family history of hypertension or diabetes mellitus.
Also, reflux nephropathy is believed to be heterogen-
eous, with congenital scarring (renal dysplasia) and
acquired scarring (pyelonephritis) having different
causes and outcomes. Such confounding variables were
not corrected for in the comparison between patients
with and those without scarring, because relevant data
were not available in retrospective studies.
Fourthly, the retrieved reports included patients
whose initial illnesses were treated at different times
(i.e. varying from the 1950s to 1980s); patients studied
more recently may have milder illness because of im-
proved detection and management of UTI and VUR.
Also, patients were assessed at varying ages (11–35
years) or after different durations of illness (9–29 years).
As reported by Goonasekera et al, 15 of 18 hypertensive
patients were diagnosed at age 15–30 years [7], thus
suggesting that studies in younger patients may not have
an adequate duration of follow-up.
Lastly, investigators used different techniques for
BP measurement (i.e. spot BP was measured with a
mercury sphygmomanometer or Dinamap® device,
whereas ambulatory BP was measured with a
SpaceLabs 90207 device). The definition of hyper-
tension also showed inter-study variability, from the
adult criterion of BP > 140/90 mmHg to criteria based
on percentile charts for either spot or ambulatory BP.
Thus, to some extent, this explains the different rates
of hypertension recorded in the various trials reviewed.
CONCLUSION
Despite the widely held belief that UTI in childhood
leads to renal scarring, with subsequent hypertension
later in life, there was little direct evidence from the
literature supporting this hypothesis. From the few
cohort studies that followed patients for an adequate
duration to adulthood, the risk of hypertension ranged
from 5.6% to 27.9%. There was a trend towards
increasing BP with worse scarring. However, only
one study reported a significantly greater risk of
hypertension in patients with versus those without
renal scarring, and four other studies, which also
included a control group of patients without renal
scarring, reported that scar-positive and scar-negative
patients had similar rates of hypertension. Overall,
the marked variability in results was probably due
to different methodologic weaknesses in the nine
studies reviewed.
Table 2. Assessing causation [18]
Demonstration of true association
- Appropriate study design with valid comparison groups
- Avoidance of recruitment, measurement, observer, or recall
bias
- Exclusion of, or correction for, confounding factors
- Exclusion of chance, or showing statistically significant
difference
Demonstration of true causation
- Temporal relationship
- Biologic sense
- Consistency across studies
- Dose-response relationship
- Strength of association
- Cessation effect
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